Brian Kai-Ming Cheng

Title: The Innovative Journey of Brian Kai-Ming Cheng

Introduction: Brian Kai-Ming Cheng is an accomplished inventor based in Chesterfield, MO, known for his contributions to the pharmaceutical field. With a focus on innovative drug delivery systems, Cheng's work demonstrates a commitment to enhancing patient care through his inventive solutions.

Latest Patents: Cheng holds a significant patent for a "Matrix-based pulse release pharmaceutical formulation." This invention relates to an oral pulse release pharmaceutical composition that features a polymer matrix core. The core not only contains one or more pharmaceutically active ingredients distributed throughout but also features these ingredients on its outer surface. Notably, amphetamine salts can be part of this formulation, showcasing its versatility. Additionally, his invention includes methods for creating an immediate release component in solid pharmaceutical formulations.

Career Highlights: Brian Cheng is a vital part of Mallinckrodt, Inc., a company renowned for its pharmaceutical innovations. His role there allows him to develop cutting-edge technologies that address complex health challenges. With a firm foundation in pharmaceutical sciences, Cheng's work is a testament to his dedication to advancing medical technology.

Collaborations: Collaboration is often key to innovation, and Cheng has worked alongside talented colleagues such as Ashwini Gadre and Mark R Benmuvhar. Together, they contribute their expertise to drive forward-thinking research and development initiatives at Mallinckrodt.

Conclusion: Brian Kai-Ming Cheng exemplifies the innovative spirit necessary for progress in the pharmaceutical industry. His patent on a matrix-based pulse release pharmaceutical formulation demonstrates his ingenuity and commitment to improving drug delivery methods. As he continues to collaborate with esteemed colleagues at Mallinckrodt, the potential for further innovations remains strong.